11 December 2018

[Reminder] Circular # 171 Modification Of Dispensing Pharmaceutical Product (Buprenorphine )

Reference: CIR-2018-SHN0887

To: All health facilities / all health care practitioners in Dubai's private health sector:

Please refer to the circular # 171 regarding the Modification of dispensing pharmaceutical product (Buprenorphine)

and get the details of the circular through the following link:

Important links:

Supporting Documents:

circular no. 171 Modification of dispensing pharmaceutical product ( Buprenorphine ).pdf:

View Document